Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016 (2016), Article ID 6262383, 6 pages
http://dx.doi.org/10.1155/2016/6262383
Review Article

Emerging Technologies and Generic Assays for the Detection of Anti-Drug Antibodies

1Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA
2UCB Pharma, Slough, Berkshire SL1 14EN, UK
3Department of Biochemical & Cellular Pharmacology, Genentech Inc., South San Francisco, CA 94080, USA

Received 20 April 2016; Revised 26 May 2016; Accepted 9 June 2016

Academic Editor: Eyad Elkord

Copyright © 2016 Michael A. Partridge et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [3 citations]

The following is the list of published articles that have cited the current article.

  • Nidhi Nath, Rod Flemming, Becky Godat, and Marjeta Urh, “Development of NanoLuc bridging immunoassay for detection of anti-drug antibodies,” Journal of Immunological Methods, 2017. View at Publisher · View at Google Scholar
  • S. Louis Bridges, Douglas W. White, Angus B. Worthing, Ellen M. Gravallese, James R. O'Dell, Kamala Nola, Jonathan Kay, and Stanley B. Cohen, “The Science Behind Biosimilars,” Arthritis & Rheumatology, 2018. View at Publisher · View at Google Scholar
  • Minoru Tada, Takuo Suzuki, and Akiko Ishii-Watabe, “Development and characterization of an anti-rituximab monoclonal antibody panel,” mAbs, pp. 00–00, 2018. View at Publisher · View at Google Scholar